Among the targets, MAPK1 and MAP2K1, two crucial proteins in MAPK signaling pathways, were further studied based on the fact that MAPK pathways were confirmed to be involved in MDR in lung cancer [18]. The gene discussed is MAPK1; the disease is lung carcinoma.